The National Cataract Audit is currently funded through participation fees from centres as well as financial contributions from Alcon, Bausch + Lomb and Rayner.
The Age-Related Macular Degeneration (AMD) Audit is currently kindly funded by the Macular Society, Novartis, Roche and Bayer. This project has been supported by a financial grant from Bayer Plc. Bayer Plc has had no involvement whatsoever in the development or implementation of the project.
